Urology News CME

• FDA Safety Changes: Prevpac, Arava, Treanda CME/CE The FDA has approved safety labeling revisions for a prepackaged regimen of lansoprazole, amoxicillin, and clarithromycin tablets; leflunomide tablets; and bendamustine HCl intravenous infusion.
  Medscape Medical News CME, July 2009
• Enalapril, Losartan May Have Retinal, but Not Renal, Benefits in Type 1 Diabetes CME In a controlled trial, early blockade of the renin-angiotensin system did not slow the progression of nephropathy but slowed the progression of retinopathy in patients with type 1 diabetes.
  Medscape Medical News CME, July 2009
• New Hemoglobin Target Levels in Chronic Kidney Disease Suggested CME A meta-analysis shows that targeting hemoglobin levels higher than 12.0 g/dL leads to small and not clinically meaningful improvements in health-related quality of life, despite safety concerns.
  Medscape Medical News CME, July 2009
• Lower Urinary Tract Symptoms Associated With Metabolic Syndrome CME Results of a study suggest that even mild lower urinary tract symptoms are significantly associated with metabolic syndrome in men younger than 60 years.
  Reuters Health Information CME, June 2009
• Chronic Kidney Disease Linked to Risk for Hyperkalemia and Associated Mortality CME A retrospective analysis of a national cohort shows that risk for hyperkalemia is increased with chronic kidney disease, and its occurrence increases the odds of mortality within 1 day of the event.
  Medscape Medical News CME, June 2009
• Patients With Atherosclerotic Renal Artery Stenosis May Not Benefit from Stent Placement CME In a randomized trial, stent placement with medical treatment had no clear effect on progression of renal impairment but led to a small number of significant procedure-related complications.
  Medscape Medical News CME, June 2009
• Roux-En-Y Gastric Bypass Surgery Linked to Kidney Stones CME In a study of insurance claims data, Roux-en-Y gastric bypass surgery was associated with an increased risk for kidney stone disease and kidney stone surgery in the postoperative period.
  Medscape Medical News CME, June 2009
• Overused: Androgen-Deprivation Therapy in Prostate Cancer CME Editorials in 2 major journals call for more judicious use of androgen-deprivation therapy in the treatment of prostate cancer.
  Medscape Medical News CME, June 2009
• Quadrivalent HPV Vaccine May Be Effective in Women 24 to 45 Years Old CME In a randomized trial, the quadrivalent human papillomavirus vaccine was efficacious in women aged 24 to 45 years who were not infected with the relevant types at enrollment.
  Medscape Medical News CME, June 2009
• Urinary Incontinence Highly Prevalent in Overweight, Obese Women With Type 2 Diabetes CME A cross-sectional analysis shows that increasing obesity is the strongest modifiable risk factor for overall incontinence and stress incontinence in women with type 2 diabetes.
  Medscape Medical News CME, June 2009
• FDA Safety Changes: Remicade and Doribax CME/CE The FDA has approved safety labeling revisions for infliximab intravenous infusion (Remicade) and doripenem intravenous infusion (Doribax).
  Medscape Medical News, June 2009
• Clinical Practice Intervention May Increase Chlamydia Screening in Teen Girls CME Clinical Practice Intervention May Increase Chlamydia Screening in Teen Girls
  Medscape Medical News, June 2009
• Vitamin D Deficiency Linked to Bacterial Vaginosis CME/CE The association of vitamin D deficiency and bacterial vaginosis may contribute to the strong racial disparity in the prevalence of bacterial vaginosis in the first trimester of pregnancy.
  Medscape Medical News, June 2009
• Overnight Dialysis Is a Good Option for Some Patients With Irreversible Kidney Disease CME Long overnight dialysis is more convenient and beneficial for some patients with irreversible kidney disease and may be especially suitable in dialysis clinics where there are constraints on time and resources.
  Medscape Medical News, May 2009
• Early vs Deferred Antiretroviral Therapy May Reduce AIDS Progression and Death CME In a randomized trial, early vs late antiretroviral therapy was associated with approximately half the rate of AIDS progression and death, with no increase in adverse events or loss of virologic response.
  Medscape Medical News, May 2009
• USPSTF Recommends Syphilis Screening for All Pregnant Women CME The US Preventive Services Task Force has reaffirmed its recommendation to screen all pregnant women for syphilis infection.
  Medscape Medical News, May 2009
• Sodium Bicarbonate-Based Hydration May Help Prevent Contrast-Induced Nephropathy CME An updated meta-analysis suggests that sodium bicarbonate-based hydration is better than normal saline in preventing contrast-induced nephropathy.
  Medscape Medical News, May 2009
• Tamsulosin Use Linked to Serious Ophthalmic Adverse Events After Cataract Surgery CME Use of tamsulosin within 14 days of cataract surgery, but not of other alpha-blocker medications used to treat benign prostatic hyperplasia, was significantly associated with serious postoperative ophthalmic adverse events.
  Medscape Medical News, May 2009
• ADT Increases Risk for Fractures and Cardiovascular-Related Death in Prostate Cancer Patients CME Although the absolute risk is low, androgen-deprivation therapy is associated with an increased risk for skeletal fracture, incident diabetes, and cardiovascular-related mortality in patients with prostate cancer.
  Medscape Medical News, May 2009
• FDA Safety Changes: Axert, Tarka, Macrobid, Macrodantin CME/CE The FDA has approved safety labeling revisions for almotriptan malate tablets (Axert), verapamil HCl/trandolapril tablets (Tarka), and nitrofurantoin monohydrate/macrocrystals capsules (Macrobid and Macrodantin).
  Medscape Medical News, May 2009